Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants
2020 · Nature Communications · 250 citations
https://doi.org/10.1038/s41467-020-19230-w
T
Thierry VandenDriessche
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
267
Papers
10.4K
Citations
54
h-index
110
i10-index
Thierry VandenDriessche is an academic researcher from Vrije Universiteit Brussel. The author has contributed to research in topics: Virus-based gene therapy research & CRISPR and Genetic Engineering & RNA Interference and Gene Delivery. The author has an h-index of 54, co-authored 227 publications.
ORCID: 0000-0003-4230-745XPapers by this author
worksLiver-Specific Transcriptional Modules Identified by Genome-Wide In Silico Analysis Enable Efficient Gene Therapy in Mice and Non-Human Primates
2014 · Molecular Therapy · 77 citations
https://doi.org/10.1038/mt.2014.114
Next-generation muscle-directed gene therapy by in silico vector design
2019 · Nature Communications · 55 citations
https://doi.org/10.1038/s41467-018-08283-7
First hemophilia B gene therapy approved: More than two decades in the making
2022 · Molecular Therapy · 31 citations
https://doi.org/10.1016/j.ymthe.2022.12.001
First conditional marketing authorization approval in the European Union for hemophilia “A” gene therapy
2022 · Molecular Therapy · 30 citations
https://doi.org/10.1016/j.ymthe.2022.09.020
Hemophilia gene therapy knowledge and perceptions: Results of an international survey
2020 · Research and Practice in Thrombosis and Haemostasis · 21 citations
https://doi.org/10.1002/rth2.12326
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat